| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.7B | $51.7B | $61.3B | $52.6B | $44.0B | $9.7B | $9.9B | $9.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $2.2B | $2.0B | $2.0B |
| R&D Expense | $2.3B | $2.3B | $2.2B | $1.9B | $1.6B | $1.6B | $1.8B | $1.7B |
| SG&A Expense | $4.7B | $4.8B | $4.6B | $3.9B | $3.4B | $3.5B | $3.6B | $3.5B |
| Operating Income | — | $9.0B | $13.0B | $9.5B | $8.0B | $4.3B | $4.4B | $4.5B |
| Net Income | $5.0B | $7.1B | $10.2B | $7.1B | $6.0B | $0.8B | $0.7B | $0.8B |
| EPS (Basic) | $18.55 | $25.73 | $34.80 | $23.42 | $19.14 | $2.41 | $2.30 | $2.45 |
| EPS (Diluted) | $18.50 | $25.62 | $34.63 | $23.28 | $18.99 | $2.39 | $2.27 | $2.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $106.0B | $107.3B | $104.1B | $90.0B | $84.1B | $75.1B | $73.0B | $70.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $8.3B | $7.3B | $7.5B | $4.8B | $8.0B | $7.1B | $3.9B | $3.9B |
| Total Liabilities | $80.0B | $84.4B | $82.2B | $69.7B | $65.7B | $62.1B | $61.6B | $58.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $25.9B | $22.8B | $21.8B | $20.3B | $18.4B | $12.9B | $11.4B | $11.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.5B | $9.2B | $8.6B | $4.7B | $7.7B | $7.5B | $3.4B | $1.8B |
| Investing Cash Flow | $-2.1B | $-6.5B | $-8.7B | $-8.5B | $-5.8B | $-3.3B | $-3.9B | $-8.2B |
| Capital Expenditures | $1.4B | $1.6B | $1.5B | $1.1B | $0.8B | $0.8B | $1.1B | $0.9B |
| Financing Cash Flow | $-4.6B | $-2.7B | $2.8B | $0.8B | $-1.1B | $-1.0B | $0.5B | $0.9B |